Intraperitoneal delivery of iopamidol to assess extracellular ph of orthotopic pancreatic tumor model by cest-mri

HIGHLIGHTS

  • who: Bruna Victorasso Jardim-Perassi and collaborators from the Department of Cancer Physiology, HLee Moffitt Cancer Center and Research Institute, Tampa, FL, USA Department of Biological Sciences, University of Illinois, Chicago, IL, USA have published the Article: Intraperitoneal Delivery of Iopamidol to Assess Extracellular pH of Orthotopic Pancreatic Tumor Model by CEST-MRI, in the Journal: Contrast Media and Molecular Imaging 40 min postcontrast of 29/08/2022
  • what: The authors optimized intraperitoneal (IP) delivery of iopamidol to facilitate longitudinal assessments of orthotopic pancreatic tumor pHe by CEST-MRI. This study shows the applicability of . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?